# Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

> **NCT01706432** · — · COMPLETED · sponsor: **University of Chicago** · enrollment: 4 (actual)

## Conditions studied

- Central Nervous System Metastases
- Invasive Ductal Breast Carcinoma
- Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
- Invasive Lobular Breast Carcinoma
- Invasive Lobular Breast Carcinoma With Predominant in Situ Component
- Liver Metastases
- Lobular Breast Carcinoma in Situ
- Lung Metastases
- Male Breast Cancer
- Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
- Mucinous Ductal Breast Carcinoma
- Papillary Ductal Breast Carcinoma
- Recurrent Breast Cancer
- Stage IV Breast Cancer
- Tubular Ductal Breast Carcinoma
- Tumors Metastatic to Brain

## Interventions

- **RADIATION:** hyperfractionated radiation therapy
- **OTHER:** laboratory biomarker analysis
- **RADIATION:** stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT01706432
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-15
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-01-22
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706432, "Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01706432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*